|
[1] Takahashi K,Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast culture by defined factors. Cell, 2006, 126:663-676.
[2] Yonehiro Kanemura. Development of cell-processing systems for human stem cells(neural stem cells,mesenchymal stem cells,and iPS cells)for regenerative medicine. Keio J Med, 2010, 59(2):35-45.
[3] Takahashi K,Tanabe K,Ohnuki M,et al.Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 2007, 13l(5):861-872.
[4] Yu J,Vodyanik M A,Smuga-Otto K,et al. Induced pluripotent stem cell lines derived from human somatic cells. Science, 2007, 318:1917-1920.
[5] Stadtfeld M,Hochedlinger K. Induced pluripotency:history,mechanisms,and applications. Genes Dev, 2010, 24(20):2239-2263.
[6] Zhao X Y,Li W,Lv Z,et al. iPS cells produce viable mice through tetraploid complementation. Nature, 2009, 461(7260):86-90.
[7] Nakagawa M,Takizawa N,Narita M,et al. Promotion of direct reprogramming by transformation-deficient Myc. Proc Natl Acad Sci USA, 2010,107(32):14152-14157.
[8] De Coppi P,Bartsch G Jr,Siddiqui M M,et al. Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol, 2007, 25:100-106.
[9] Li C,Zhou J,Shi G,et al. Pluripotency can be rapidly and efficiently induced in human amniotic fluid-derived cells. Hum Mol Genet, 2009, 18(22):4340-4349.
[10] Raya A,Rodríguez-Pizà I,Guenechea G,et al. Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells. Nature, 2009, 460(7251):53-59.
[11] Stadtfeld M,Nagaya M,Utikal J,et al. Induced pluripotent stem cells generated without viral integration. Science, 2008, 322(5903):945-949.
[12] Honda A,Hirose M,Hatori M,et al. Generation of induced pluripotent stem cells in rabbits:potential experimental models for human regenerative medicine. J Biol Chem, 2010, 285(41):31362-31369.
[13] Yamanaka S. Patient-specific pluripotent stem cells become even more accessible. Cell Stem Cell, 2010, 7(1):1-2.
[14] Okita K,Nakagawa M,Hyenjong H,et al. Generation of mouse induced pluripotent stem cells without viral vectors. Science, 2008, 322(5903):949-953.
[15] Yu J,Hu K,Smuga-Otto K,et al. Human induced pluripotent stem cells free of vector and transgene sequences. Science, 2009, 324(5928):797-801.
[16] Okita K,Hong H,Takahashi K,et al. Generation of mouse-induced pluripotent stem cells with plasmid vectors. Nat Protoc, 2010, 5(3):418-428.
[17] Jia F,Wilson K D,Sun N,et al. A nonviral minicircle vector for deriving human iPS cells. Nat Methods, 2010,7(3):197-199.
[18] Woltjen K,Michael I P,Mohseni P,et al. piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature, 2009, 458(7239):766-770.
[19] Wang W,Lin C,Lu D,et al. Chromosomal transposition of PiggyBac in mouse embryonic stem cells. Proc Natl Acad Sci USA, 2008, 105(27):9290-9295.
[20] Ichida J K,Blanchard J,Lam K,et al. A small-molecule inhibitor of tgf-Beta signaling replaces sox2 in reprogramming by inducing nanog. Cell Stem Cell, 2009, 5(5):491-503.
[21] Zhu S,Li W,Zhou H,et al. Reprogramming of human primary somatic cells by OCT4 and chemical compounds. Cell Stem Cell, 2010, 7(6):651-655.
[22] Hong H,Takahashi K,Ichisaka T,et al. Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. Nature, 2009, 460(7259):1132-1135.
[23] Utikal J,Polo J M,Stadtfeld M,et al. Immortalization eliminates a roadblock during cellular reprogramming into iPS cells. Nature, 2009, 460(7259):1145-1148.
[24] Marión R M,Strati K,Li H,et al. A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity. Nature, 2009, 460(7259):1149-1153.
[25] Li H,Collado M,Villasante A,et al. The Ink4/Arf locus is a barrier for iPS cell reprogramming. Nature, 2009, 460(7259):1136-1139.
[26] Zhao Y,Yin X,Qin H,et al. Two supporting factors greatly improve the efficiency of human iPSC generation. Cell Stem Cell, 2008, 3(5):475-479.
[27] Shi M,Liu D,Shen B,et al. Helpers of the cellular gatekeeper-miRNAs dance in P53 network. Biochim Biophys Acta, 2010, 1805(2):218-225.
[28] Huangfu D,Maehr R,Guo W,et al. Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nat Biotechnol, 2008, 26(7):795-797.
[29] Yoshida Y,Takahashi K,Okita K,et al. Hypoxia enhances the generation of induced pluripotent stem cells. Cell Stem Cell, 2009, 5(3):237-241.
[30] Chen T,Yuan D,Wei B,et al. E-cadherin-mediated cell-cell contact is critical for induced pluripotent stem cell generation. Stem Cells, 2010, 28(8):1315-1325.
[31] Zhou Q,Yan B,Hu X,et al. Luteolin inhibits invasion of prostate cancer PC3 cells through E-cadherin. Mol Cancer Ther, 2009,8:1684-1691.
[32] Buszczak M,Paterno S,Spradling A C. Drosophila stem cells share a common requirement for the histone H2B ubiquitin protease scrawny. Science, 2009, 323(5911):248-251.
[33] Nishino J,Kim I,Chada K,et al. Hmga2 promotes neural stem cell self-renewal in young but not old mice by reducing p16Ink4a and p19Arf Expression. Cell, 2008, 135(2):227-239.
[34] Yang Y,Xu S,Xia L,et al. The bantam microRNA is associated with drosophila fragile X mental retardation protein and regulates the fate of germline stem cells. PLoS Genet, 2009, 5(4):1-10.
[35] Karumbayaram S,Novitch B G,Patterson M,et al. Directed differentiation of human-induced pluripotent stem cells generates active motor neurons. Stem Cells, 2009, 27(4):806-811.
[36] Kou Z,Kang L,Yuan Y,et al. Mice cloned from induced pluripotent stem cells(iPSCs). Biol Reprod, 2010, 83(2):238-243.
[37] Ueda K,Takano H,Niitsuma Y,et al. Sonic hedgehog is a critical mediator of erythropoietin-induced cardiac protection in mice. J Clin Invest, 2010, 120(6):2016-2029.
[38] Bhutani N,Brady J J,Damian M,et al. Reprogramming towards pluripotency requires AID-dependent DNA demethylation. Nature, 2010, 463(7284):1042-1047.
[39] Nakagawa M,Takizawa N,Narita M,et al. Promotion of direct reprogramming by transformation-deficient Myc. Proc Natl Acad Sci U S A, 2010, 107(32):14152-14157.
[40] Sun N,Longaker M T,Wu J C. Human iPS cell-based therapy:considerations before clinical applications. Cell Cycle,2010,9(5):880-885.
[41] Li R,Liang J,Ni S,et al. A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts. Cell Stem Cell, 2010, 7(1):51-63.
|